WLK Westlake Chemical Corporation

$74.95

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 1/6/2026

About Westlake Chemical Corporation

No Company Description Available

Website: N/A

Sector
LIFE SCIENCES
Industry
INDUSTRIAL ORGANIC CHEMICALS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1262823
Address
2801 POST OAK BLVD, SUITE 600, HOUSTON, TX, US
Valuation
Market Cap
$11.80B
P/E Ratio
19.80
PEG Ratio
1.59
Price to Book
1.12
Performance
EPS
$4.64
Dividend Yield
2.29%
Profit Margin
4.96%
ROE
5.93%
Technicals
50D MA
$103.90
200D MA
$126.12
52W High
$159.32
52W Low
$81.41
Fundamentals
Shares Outstanding
128M
Target Price
$117.69
Beta
1.02

WLK EPS Estimates vs Actual

Estimated
Actual

WLK News & Sentiment

Dec 29, 2025 • MarketBeat SOMEWHAT-BEARISH
Deprince Race & Zollo Inc. Has $14.57 Million Position in Westlake Corporation $WLK
Deprince Race & Zollo Inc. reduced its stake in Westlake Corporation (NYSE:WLK) by 25.4% in Q3, now holding 189,009 shares valued at approximately $14.57 million. This comes after Westlake missed Q3 earnings estimates, reporting ($0.29) EPS against a $0.18 consensus and a 9% revenue drop to $2.84 billion. Despite insider sales from Chairman Albert Chao, institutional investors and hedge funds still own a significant portion of the company's stock.
Dec 24, 2025 • C&EN BEARISH
Dec. 23 Business Watch: Westlake closes US vinyl and styrene capacity; Samsung Biologics buys Human Genome Sciences
This article covers key business news in the chemical industry, highlighted by Westlake's decision to close vinyl and styrene capacity in the US due to market oversupply. It also details Samsung Biologics' acquisition of Human Genome Sciences from GSK to expand its US manufacturing presence. Other significant developments include insolvencies at Vynova in Europe, investments in Ineos's Grangemouth site by the UK government, and various other mergers, acquisitions, and strategic moves within the pharmaceutical and chemical sectors.
Dec 21, 2025 • MarketBeat NEUTRAL
Westlake Chemical Partners (NYSE:WLKP) Stock Rating Lowered by Wall Street Zen
Westlake Chemical Partners (NYSE:WLKP) had its stock rating downgraded from "buy" to "hold" by Wall Street Zen, consistent with an overall "Hold" rating from other analysts like Weiss and Zacks. The company reported quarterly EPS of $0.42, missing consensus by $0.01, and revenue of $308.9 million, slightly exceeding estimates. Institutional investors own approximately 78.3% of the shares.
Dec 20, 2025 • The Globe and Mail BULLISH
RBC Capital Reaffirms Their Buy Rating on Westlake Corporation (WLK)
RBC Capital analyst Arun Viswanathan maintained a Buy rating on Westlake Corporation (WLK) with a price target of $85.00. This follows Westlake's Q3 earnings report showing $2.84 billion in revenue and a GAAP net loss of $782 million, compared to a profit in the previous year. Citi also issued a Buy rating, while Morgan Stanley maintained a Hold rating on the company.
Dec 18, 2025 • The Commercial Dispatch BEARISH
Westlake Chemical closure in Aberdeen set to affect 99 workers
Westlake Chemical's polyvinyl chloride (PVC) plant in Aberdeen, Mississippi, is among three facilities closing this month, impacting around 99 workers at the Aberdeen site. The Houston-based company cited "persistent, challenging market conditions" for the closures. Local development agencies are working to connect displaced employees, many with technical skills, to new opportunities within the Golden Triangle region.
Dec 17, 2025 • Chron BEARISH
Houston chemical giant slashes jobs as Gulf Coast plants shut down
Westlake Corporation, a Houston-based chemical manufacturer, is laying off 295 employees and closing four Gulf Coast facilities due to low market pricing and increased low-priced Asian exports. These closures will result in approximately $415 million in pre-tax costs, including significant non-cash charges and employee severance. The company plans to continue supplying products from its remaining seven North American facilities.
Sentiment Snapshot

Average Sentiment Score:

-0.181
50 articles with scored sentiment

Overall Sentiment:

Bearish

WLK Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Pre market)
-1.2 Surprise
  • Reported EPS: $-1.11
  • Estimate: $0.09
  • Whisper:
  • Surprise %: -1333.3%
May 02, 2025
Mar 31, 2025 (Pre market)
-1.01 Surprise
  • Reported EPS: $-0.31
  • Estimate: $0.69
  • Whisper:
  • Surprise %: -144.9%
Feb 24, 2025
Dec 31, 2024 (Pre market)
-0.76 Surprise
  • Reported EPS: $0.41
  • Estimate: $1.17
  • Whisper:
  • Surprise %: -65.0%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.79 Surprise
  • Reported EPS: $1.41
  • Estimate: $2.20
  • Whisper:
  • Surprise %: -35.9%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.41 Surprise
  • Reported EPS: $2.40
  • Estimate: $1.99
  • Whisper:
  • Surprise %: 20.6%
May 01, 2024
Mar 31, 2024 (Pre market)
0.31 Surprise
  • Reported EPS: $1.34
  • Estimate: $1.03
  • Whisper:
  • Surprise %: 30.1%
Feb 20, 2024
Dec 31, 2023 (Pre market)
-0.18 Surprise
  • Reported EPS: $0.72
  • Estimate: $0.90
  • Whisper:
  • Surprise %: -20.0%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.23 Surprise
  • Reported EPS: $2.20
  • Estimate: $1.97
  • Whisper:
  • Surprise %: 11.7%
Aug 03, 2023
Jun 30, 2023 (Pre market)
-0.62 Surprise
  • Reported EPS: $2.31
  • Estimate: $2.93
  • Whisper:
  • Surprise %: -21.2%

Financials